Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.
about
Architecture and expression of the nfatc1 gene in lymphocytesEvaluating genome-wide DNA methylation changes in mice by Methylation Specific Digital Karyotyping.Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1)Application of ChIP-Seq and related techniques to the study of immune function.Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis.Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive LymphomasNFATc1/αA: The other Face of NFAT Factors in Lymphocytes.Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.NFATc1 releases BCL6-dependent repression of CCR2 agonist expression in peritoneal macrophages from Saccharomyces cerevisiae infected mice.Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts.Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling.Induction of Short NFATc1/αA Isoform Interferes with Peripheral B Cell Differentiation.Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia.NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway
P2860
Q26865323-CBCF3C8C-573C-44CB-A4C2-A2EB7A8546DBQ33392446-90131C68-E4F9-4E97-947E-A0D59D27FDE1Q34572768-C1F9ED8D-57BC-4B52-B223-25C241322118Q35108215-CF49FFCF-6E61-484E-A75B-7EF8B15DDF2AQ36345656-612584AC-5AAB-4FC5-99F0-F5408E87EDA6Q36747299-738BBA02-C1E4-4C52-AD1A-8DFF278B0946Q36994797-06F3A6DC-BC37-47EB-9EED-704B06F6F25DQ38644718-349A2753-FE2E-44A3-9952-7C98002795E5Q39591211-19741095-EE35-4E61-8773-7B1F6939E5C0Q40089637-0F412A62-15CD-4944-B4B4-9C4E34B0657EQ40885164-9AAFDA7D-B853-4CD5-806F-34C9842A4A66Q42061814-F02B8AE6-37C4-48C5-A798-28C9A8EB270AQ46530451-34966F49-270B-4613-9497-A04B1ED5D8BAQ49254351-B86FF993-CFB5-4A9B-AE16-238A8336A5DCQ50978065-EC26BDE0-2335-48B4-A8DD-111ADCC6C97DQ58796653-0C12A767-5C13-42FE-9C9B-60253996AD04
P2860
Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epigenetic changes and suppres ...... s in immunoreceptor signaling.
@en
type
label
Epigenetic changes and suppres ...... s in immunoreceptor signaling.
@en
prefLabel
Epigenetic changes and suppres ...... s in immunoreceptor signaling.
@en
P2093
P2860
P1476
Epigenetic changes and suppres ...... s in immunoreceptor signaling.
@en
P2093
Alois Palmetshofer
Andris Avots
Askar Akimzhanov
Edgar Serfling
Eisaku Kondo
Enikö Bagdi
Eva Stelkovics
Hans-Konrad Müller-Hermelink
Laszlo Krenacs
Philipp Wilke
P2860
P304
P356
10.2353/AJPATH.2008.070294
P407
P577
2007-12-21T00:00:00Z